Class   530	CHEMISTRY: NATURAL RESINS OR DERIVATIVES; PEPTIDES OR PROTEINS; LIGNINS OR REACTION PRODUCTS THEREOF
	Click here to view a PDF version of this file

This Class 530 is considered to be an integral part of Class 260 (see the Class 260 schedule for the position of this Class in schedule hierarchy). This Class retains all pertinent definitions and class lines of Class 260.

200

NATURAL RESINS OR DERIVATIVES (E.G., WOOD OR PINE TAR; CATIVO RESIN DERIVATIVES, ETC.)

201

. (1 indent ) Shellac containing starting material used in process, or product thereof (e.g., lac, sticklac, seedlac, flake shellac, bleached shellac, etc.)

202

. (1 indent ) Cut wood starting material used in process, or product thereof (e.g., using pine stumps, chips, bark, etc., as starting material)

203

. (1 indent ) Plant sap or fossil starting material used in process, or product thereof (e.g., using copal, coal, amber, dammar, etc., as starting material)

204

.. (2 indent ) Pine oleoresin starting material used in process, or product thereof (e.g., using gum turpentine, pine gum, pine resin, etc., as starting material)

205

. (1 indent ) Recovery of tall oil or derivatives from papermaking waste, purification of tall oil, or separation of components of tall oil; or product thereof (e.g., separation of rosin, fatty acids, sterols, etc.; decolorizing, etc.)

206

.. (2 indent ) Organic sulfur or nitrogen containing material used in the process, or product thereof

207

.. (2 indent ) Esterification used in the process, or product thereof

208

.. (2 indent ) Inorganic material used in the process, or product thereof (e.g., using sulfuric acid, boric acid, etc.)

209

... (3 indent ) Phosphorus or heavy metal containing material, elemental hydrogen, sulfur dioxide, or carbon dioxide used in the process, or product thereof

210

. (1 indent ) Rosin or derivative used as starting material in process, or product thereof (e.g., using gum rosin, wood rosin, solid tall oil rosin, etc.)

211

.. (2 indent ) Polymerization or product thereof (e.g., dimer rosin, etc.)

212

... (3 indent ) Chemical treatment or color modification of polymerized rosin or derivative, or product thereof (e.g., hydrogenation or esterification of polymerized rosin; removal of color bodies from polymerized rosin, etc.)

213

.. (2 indent ) Boron or phosphorus containing material used in the process, or product thereof

214

.. (2 indent ) Diels-Alder adducts (e.g., of maleic anhydride, fumaric acid, etc., with conjugated dienes, such as rosin acids, terpenes, etc.)

215

.. (2 indent ) Esterification of rosin or derivative via carboxyl group, or product thereof

216

... (3 indent ) Chemical treatment or color modification of esterified rosin or derivative, or product thereof (e.g., partial saponification of rosin triglycerides; removal of color bodies from rosin esters, etc.)

217

... (3 indent ) Oxygen containing ring or halogen containing material used in the esterification, or product thereof (e.g., using alkylene oxides, polysaccharides, alkyl halides, etc.)

218

... (3 indent ) Polyhydroxy material used in the esterification, or product thereof (e.g., forming ester gum, etc.)

219

.. (2 indent ) Sulfur, selenium, or tellurium containing material used in the process, or product thereof (e.g., disproportionation of rosin, etc.)

220

... (3 indent ) The sulfur, selenium, or tellurium containing material is inorganic

221

.. (2 indent ) Nitrogen containing material used in the process, or product thereof

222

... (3 indent ) The nitrogen containing material is inorganic

223

.. (2 indent ) Hydrogenation or product thereof (e.g., forming dihydro rosin acids; rosinyl alcohol or derivatives; etc.)

224

.. (2 indent ) Metal containing material used to form salts of rosin acids, or product thereof

225

... (3 indent ) Alkali metal containing material (i.e., Li, Na, K, Rb or Cs)

226

.. (2 indent ) Heat treatment of rosin or derivative in the absence of nonrosin organic reactants, or product thereof (e.g., forming rosin oil; disproportionated, dehydrogenated, or isomerized rosin; etc.)

227

... (3 indent ) Metal, halogen, or silicon containing material used in the process, or product thereof (e.g., using clay, zeolites, etc.)

228

.. (2 indent ) Purification process or product thereof

229

... (3 indent ) Immiscible solvents used in the process, or product thereof

230

. (1 indent ) Tall oil or derivative used as starting material in process, or product thereof (e.g., metal salts of tall oil fatty acids; tall oil pitch, etc.) dehydrogenated, or isomerized rosin; etc.)

231

.. (2 indent ) Nitrogen containing material used in the process, or product thereof

232

.. (2 indent ) Esterification of tall oil acids, or product thereof

233

.. (2 indent ) Sulfur, boron, phosphorus, or iodine containing material used in the process, or product thereof

300

PEPTIDES OF 3 TO 100 AMINO ACID RESIDUES

301

. (1 indent ) Thymopoietin or Lipotropin; related peptides

302

. (1 indent ) Endorphin and Enkephalin; related peptides

303

. (1 indent ) Insulin; related peptides

304

.. (2 indent ) Metal complexes, e.g., Zn-insulin, etc.

305

.. (2 indent ) Isolation or purification

306

. (1 indent ) Corticotropin (ATCH); related peptides

307

. (1 indent ) Calcitonin; related peptides

308

. (1 indent ) Glucagon; related peptides

309

. (1 indent ) Secretin or gastrin; related peptides

310

. (1 indent ) Gramicidin or Tyrocidin; related peptides

311

. (1 indent ) Somatostatin (SRIF); related peptides

312

. (1 indent ) Melanotropin (MSH) or eledoisin; related peptides

313

. (1 indent ) Lutenizing hormone releasing factor (LRF); related peptides

314

. (1 indent ) Bradykinin; kallidin; related peptides

315

. (1 indent ) Oxytocin; vasopressin; related peptides

316

. (1 indent ) Angiotensin; related peptides

317

. (1 indent ) Cyclic peptides

318

.. (2 indent ) The cyclisation occurring through the 4-amino radical of 2,4-diamino butanoic acid

319

... (3 indent ) Polymyxin; related peptides

320

.. (2 indent ) Bacitracin; related peptides

321

.. (2 indent ) Containing only normal peptide links in the ring, i.e., homodetic cyclic peptides

322

. (1 indent ) Peptides containing saccharide radicals, e.g., bleomycins, etc.

323

. (1 indent ) Peptides with at least one nonpeptide bond other than a disulfide bond joining two or more sequences of amino acid residues, e.g., homomeric heterodectic peptide other than cyclic disulfide, depsipeptides, etc.

324

. (1 indent ) 25 or more amino acid residues in defined sequence

325

. (1 indent ) 24 amino acid residues in defined sequence

326

. (1 indent ) 15 to 23 amino acid residues in defined sequence

327

. (1 indent ) 11 to 14 amino acid residues in defined sequence

328

. (1 indent ) 8 to 10 amino acid residues in defined sequence

329

. (1 indent ) 6 to 7 amino acid residues in defined sequence

330

. (1 indent ) 4 to 5 amino acid residues in defined sequence

331

. (1 indent ) Tripeptides, e.g., tripeptide thyroliberin (TRH), melanostatin (MIF), etc.

332

. (1 indent ) Containing at least one abnormal peptide link, e.g., gamma peptide bonded, etc.

333

. (1 indent ) Synthesis of peptides

334

.. (2 indent ) Polymer supported synthesis, e.g., solid phase synthesis, Merrifield synthesis, etc.

335

.. (2 indent ) Protecting or removing protective groups, e.g., carboxyl group protection, etc.

336

... (3 indent ) Of side chain or sulfur containing group

337

... (3 indent ) Of amino group

338

.. (2 indent ) Solution phase synthesis

339

... (3 indent ) Segment condensation, e.g., Ugi condensation, etc.

340

... (3 indent ) With phosphorus containing material

341

... (3 indent ) With use of carbonimide or imidiazole

342

... (3 indent ) Mixed anhydride synthesis

343

.. (2 indent ) By hydrolysis

344

. (1 indent ) Separation or purification

345

. (1 indent ) Chemical aftertreatment, e.g., acylation, methylation, etc.

350

PROTEINS, I.E., MORE THAN 100 AMINO ACID RESIDUES

351

. (1 indent ) Lymphokines, e.g., interferons, interlukins, etc.

352

. (1 indent ) Phosphoproteins, e.g., phosvitin, vitellogenin, etc.

353

. (1 indent ) Scleroproteins, e.g., fibroin, elastin, silk, etc.

354

.. (2 indent ) Gelatin

355

... (3 indent ) Separation, purification or synthesis

356

.. (2 indent ) Collagen

357

.. (2 indent ) Keratin

358

. (1 indent ) Nucleoproteins, e.g., chromatin, chromosomal proteins, histones, protamines, salmine, etc.

359

. (1 indent ) Lipoproteins, e.g., egg yolk proteins, cylomicrons, etc.

360

. (1 indent ) Casein or caseinate

361

.. (2 indent ) Separation, purification or synthesis

362

. (1 indent ) Albumin

363

.. (2 indent ) Serum albumin, e.g., BSA, HSA, etc.

364

... (3 indent ) Separation, purification or synthesis

365

.. (2 indent ) Lactalbumin, e.g., milk source, etc.

366

... (3 indent ) Separation, purification or synthesis

367

.. (2 indent ) Ovalalbumin, e.g., avidin, conalbumins, etc.

368

... (3 indent ) Separation, purification or synthesis

369

.. (2 indent ) Separation, purification or synthesis

370

. (1 indent ) Plant proteins, e.g., derived from legumes, algae or lichens, etc.

371

.. (2 indent ) Derived from fungi, e.g., yeasts, mushroom, etc.

372

.. (2 indent ) Derived from grain, e.g., prolamines, etc.

373

... (3 indent ) Zein

374

... (3 indent ) Gluten or gliadin

375

... (3 indent ) Derived from wheat

376

... (3 indent ) Derived from corn

377

.. (2 indent ) Derived from oil seed, e.g., cotton seed, rapeseed, sunflower, etc.

378

... (3 indent ) Derived from soybean

379

.. (2 indent ) Derived from leafy green plants, e.g., alfalfa pollen, etc.

380

. (1 indent ) Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc.

381

.. (2 indent ) Blood coagulation factors and fibrin, e.g., thromboplastin, etc.

382

... (3 indent ) Fibrin or fibrin intermediates, e.g., fibrinogen, etc.

383

... (3 indent ) Blood coagulation factor VIII, AHF

384

... (3 indent ) Blood coagulation factor II or factor II + VII + IX + X, i.e., prothrombin complex or factor

385

.. (2 indent ) Hemoglobins or globins

386

.. (2 indent ) Globulins

387.1

... (3 indent ) Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed

387.2

.... (4 indent ) Anti-idiotypic

387.3

.... (4 indent ) Chimeric, mutated, or recombined hybrid (e.g., bifunctional, bispecific, rodent-human chimeric, single chain, rFv, immunoglobulin fusion protein, etc.)

387.5

.... (4 indent ) Binds oligosaccharide structure

387.7

.... (4 indent ) Binds expression product of cancer-related gene or fragment thereof (e.g., oncogene, proto-oncogene, etc.)

387.9

.... (4 indent ) Binds specifically-identified amino acid sequence

388.1

.... (4 indent ) Monoclonal

388.15

....• (5 indent ) Human

388.2

....• (5 indent ) Binds microorganism or normal or mutant component or product thereof (e.g., animal cell, cell-surface antigen, secretory product, etc.)

388.21

....•. (6 indent ) Binds nucleic acid or derivative or component thereof (e.g., DNA, RNA, DNA-RNA hybrid, nucleotide, nucleoside, carcinogen-DNA adduct, etc.)

388.22

....•. (6 indent ) Binds receptor (e.g., transferrin receptor, Fc receptor, dihydropyridine receptor, IL-2 receptor, etc.)

388.23

....•. (6 indent ) Binds lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, or intercellular mediator specific for a hematopoietic cell (e.g., interleukin, interferon, erythropoietin, etc.)

388.24

....•. (6 indent ) Binds hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, intragonadal regulatory protein, Mullerian inhibiting substance, inhibin, epidermal growth factor, nerve growth factor, dopamine, norepinephrine, etc.)

388.25

....•. (6 indent ) Binds plasma protein, serum protein, or fibrin (e.g., clotting factor, fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.)

388.26

....•. (6 indent ) Binds enzyme

388.3

....•. (6 indent ) Binds virus or component or product thereof (e.g., virus-associated antigen, etc.)

388.35

....•.. (7 indent ) Binds retrovirus or component or product thereof (e.g., HIV, LAV, HTLV, etc.)

388.4

....•. (6 indent ) Binds bacterium or similar microorganism or component or product thereof (e.g., Stretococcus, Legionella, Mycoplasma, bacterium-associated antigen, exotoxin, etc.)

388.5

....•. (6 indent ) Binds fungus or plant cell or component or product thereof (e.g., fungus-associated antigen, etc.)

388.6

....•. (6 indent ) Binds parasitic protozoan or metazoan cell or component or product thereof (e.g., Dirofilaria, Eimeria, Coccidia, Trichinella, parasite cell-surface antigen, etc.)

388.7

....•. (6 indent ) Binds hematopoietic cell or component or product thereof (e.g., erythrocyte granulocyte, macrophage, monocyte, platelet, myelogenous leukemia cell, bone marrow stem cell, granulocytic cell-surface antigen, hemoglobin, thrombospondin, glycophorin, etc.)

388.73

....•.. (7 indent ) Binds lymphocytic or lymphocytic-like cell or component or product thereof (e.g., B cell, B-lineage bone marrow cell, null cell, natural killer cell, B-lymphoblastoid cell, B-lineage acute lymphoblastic leukemia cell, B-lymphocytic cell-surface antigen, etc.)

388.75

....•... (8 indent ) Binds T-lymphocytic cell or component or product thereof (e.g., T cell, thymocyte, T-lineage bone marrow cell, T-lymphoblastoid cell, T-lineage acute lymphoblastic leukemia cell, T-lymphocytic cell-surface antigen, etc.)

388.8

....•. (6 indent ) Binds cancer cell or component or product thereof (e.g., cell-surface antigen, etc.)

388.85

....•.. (7 indent ) Binds antigen characterized by name or molecular weight (e.g., CEA, NCA, CC glycoprotein, melanoma gp 150 antigen, etc.)

388.9

....• (5 indent ) Binds drug, hapten, hapten--carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.)

389.1

.... (4 indent ) Polyclonal antibody or immunogloblin of identified binding specificity

389.2

....• (5 indent ) Binds hormone, lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, glucagon, cardiodilatin, interleukin, interferon, norepinephrine, epinephrine, acetylcholine, etc.)

389.3

....• (5 indent ) Binds plasma protein, serum protein, or fibrin (e.g., clotting factor, fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.)

389.4

....• (5 indent ) Binds virus or component or product thereof (e.g., virus-associated antigen, etc.)

389.5

....• (5 indent ) Binds bacterium or similar microorganism or component or product thereof (e.g., Pseudomonas, Chlamydia, Clostridium, bacterium-associated antigen, etc.)

389.6

....• (5 indent ) Binds hematopoietic cell or component or product thereof (e.g., erythrocyte, granulocyte, bone marrow cell, lymphocyte, leukemic cell, hematopoietic cell-surface antigen, hemoglobin, etc.)

389.7

....• (5 indent ) Binds cancer cell or component or product thereof (e.g., cell-surface antigen, etc.)

389.8

....• (5 indent ) Binds drug, hapten, hapten-carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.)

390.1

.... (4 indent ) Removing or inactivating virus or bacterium or component or product thereof (e.g., endotoxin, etc.)

390.5

.... (4 indent ) Removing, dissociating, or preventing the formation of aggregated, denatured, fragmented, or polymerized immunoglobulin or antibody; or preventing or reducing complement fixation or binding; or reducing antigenicity; or removing, inactivating, or inhibiting contaminating plasma proteins (e.g., proteolytic enzymes, etc.)

391.1

... (3 indent ) Monoclonal or polyclonal antibody or immunoglobulin or fragment thereof that is conjugated or adsorbed (e.g., adsorbed to a solid support, etc.)

391.3

.... (4 indent ) Conjugated to a detectable label or radioisotope or radionuclide or heavy metal-containing compound

391.5

....• (5 indent ) Conjugated via a specifically-identified linking group, chelating group, coordination complex, coupling agent, or conjugation agent

391.7

.... (4 indent ) Conjugated to a cytotoxic agent, drug, or other biologically-active substance

391.9

....• (5 indent ) Conjugated via a specifically-identified linking group, coupling agent, or conjugation agent

392

... (3 indent ) Alpha globulins, e.g., ceruloplastin, haptoglobins, etc.

393

.... (4 indent ) Antithrombin III

394

... (3 indent ) Beta globulins, e.g., transferrin, etc.

395

. (1 indent ) Glycoprotein, e.g., mucins proteoglycans, etc.

396

.. (2 indent ) Lectins, e.g., concanavalin, hemagglutinin, etc.

397

.. (2 indent ) Glycoprotein hormones

398

... (3 indent ) Gonadatropins

399

. (1 indent ) Hormones, e.g., prolactin, thymosin, growth factors, etc.

400

. (1 indent ) Metal containing, e.g., chromoproteins, ferritin, ferredoxins, etc.

401

.. (2 indent ) Cytochromes, e.g., chlorophyl, orgotein, etc.

402

. (1 indent ) Chemical modification or the reaction product thereof, e.g., covalent attachment or coupling, etc.

403

.. (2 indent ) Protein is identified as an antigen, e.g., immunogenic carriers, etc.

404

... (3 indent ) Sulfur containing reactant

405

... (3 indent ) Nitrogen containing reactant

406

... (3 indent ) Oxygen containing reactant

407

.. (2 indent ) Hydrolysis of protein

408

.. (2 indent ) Sulfur containing reactant

409

.. (2 indent ) Nitrogen containing reactant

410

.. (2 indent ) Oxygen containing reactant

411

... (3 indent ) Oxygen containing is saccharide

412

. (1 indent ) Separation or purification

413

.. (2 indent ) Immunological separation or affinity chromatography

414

.. (2 indent ) Ultra filtration or osmosis

415

.. (2 indent ) Selective absorbtion, e.g., Ca phosphate sorbents, etc.

416

... (3 indent ) Ion exchange

417

... (3 indent ) Chromatography or by septum selective as to material, e.g., gel filtration, molecular sieve dialysis, etc.

418

.. (2 indent ) Precipitation

419

... (3 indent ) With added material

420

.... (4 indent ) Inorganic

421

.... (4 indent ) Polymeric, e.g., polyethylene glycol, etc.

422

.. (2 indent ) Solvent extraction

423

... (3 indent ) Oxygenated material

424

.... (4 indent ) Alcohol

425

.... (4 indent ) Carboxyl containing

426

... (3 indent ) Hydrocarbon or halogenated hydrocarbon

427

.. (2 indent ) Physical treatment

500

LIGNINS OR DERIVATIVES

501

. (1 indent ) Aldehyde, ketone or ozone reacted with a lignin or lignin containing substance, or product thereof

502

. (1 indent ) Compound which includes phenolic hydroxy or oxygen containing hetero ring reacted with a lignin or lignin containing substance, or product thereof

503

. (1 indent ) Hydrogenation of a lignin or lignin containing substance, or product thereof

504

. (1 indent ) Carboxylic acid anhydride, or a compound having halogen bonded directly to acyclic carbon by nonionic bonding, reacted with a lignin or lignin containing substance, or product thereof

505

. (1 indent ) Compound containing nitrogen attached directly or indirectly to carbon by nonionic bonding reacted with a lignin or lignin containing substance, or product therof

506

. (1 indent ) Heavy metal, aluminum, silicon or phosphorus containing

507

. (1 indent ) Processes utilizing an organic solvent or a compound having alcoholic hydroxy bonded directly to an acyclic carbon, or product thereof

	CROSS-REFERENCE ART COLLECTIONS

800

ANTIHYPERTENSIVE PEPTIDES

801

PEPTIDE SWEETNERS

802

CHROMOGENIC OR LUMINESCENT PEPTIDES

806

ANTIGENIC PEPTIDES OR PROTEINS

807

HAPTEN CONJUGATED WITH PEPTIDE OR PROTEIN

808

MATERIALS AND PRODUCTS RELATED TO GENETIC ENGINEERING OR HYBRID OR FUSED CELL TECHNOLOGY, E.G., HYBRIDOMA, MONOCLONAL PRODUCTS, ETC.

809

. (1 indent ) Fused cells, e.g., hybridoma, etc.

810

CARRIER - BOUND OR IMMOBILIZED PEPTIDES OR PROTEINS AND THE PREPARATION THEREOF, E.G., BIOLOGICAL CELL OR CELL FRAGMENT AS CARRIER, ETC.

811

. (1 indent ) Peptides or proteins is immobilized on, or in, an inorganic carrier

812

. (1 indent ) Peptides or proteins is immobilized on, or in, an organic carrier

813

.. (2 indent ) Carrier is a saccharide

814

... (3 indent ) Cellulose or derivatives thereof

815

.. (2 indent ) Carrier is a synthetic polymer

816

... (3 indent ) Attached to the carrier via a bridging agent

817

... (3 indent ) Entrapped within the carrier, e.g., gel, hollow fibre, etc.

820

PROTEINS FROM MICRO-ORGANISMS

821

. (1 indent ) Separation of nucleic acid

822

. (1 indent ) Protozoa

823

. (1 indent ) Lower fungi, e.g., mold, etc.

824

.. (2 indent ) Yeasts

825

. (1 indent ) Bacteria

826

. (1 indent ) Viruses

827

PROTEINS FROM MAMMALS OR BIRDS

828

. (1 indent ) Cancer

829

. (1 indent ) Blood

830

.. (2 indent ) Plasma; serum

831

... (3 indent ) Cohn fractions

832

. (1 indent ) Milk; colostrum

833

. (1 indent ) Whey; cheese

834

. (1 indent ) Urine; urinary system

835

.. (2 indent ) Kidney

836

. (1 indent ) Mucus; mucous glands; bursa; arthral fluid; spinal fluid

837

. (1 indent ) Lymph; lymph-glands; thymus

838

. (1 indent ) Marrow; spleen

839

. (1 indent ) Nerves; brain

840

. (1 indent ) Bones; tendons; teeth; cartilage

841

. (1 indent ) Muscles; heart

842

. (1 indent ) Skin; hair; nails; sebaceous glands; cerumen

843

. (1 indent ) Digestive system

844

.. (2 indent ) Stomach; intestine

845

.. (2 indent ) Pancreas

846

.. (2 indent ) Liver

847

.. (2 indent ) Bile

848

. (1 indent ) Lungs

849

. (1 indent ) Eyes; vessels; umbilical cord

850

. (1 indent ) Reproductive organs or embryos

851

.. (2 indent ) Placenta; amniotic fluid

852

.. (2 indent ) Sperm

853

... (3 indent ) Ovary; eggs; embryos

854

. (1 indent ) Glands

855

PROTEINS FROM ANIMALS OTHER THAN MAMMALS OR BIRDS

856

. (1 indent ) Snakes; venom

857

. (1 indent ) Fish; fish eggs; shell fish; crustacea

858

. (1 indent ) Insects; venom

859

WASTE, WASTE MATERIAL, REFUSE OR SLUDGE, E.G., EFFLUENTS, FECAL MATTER, ETC.

860

RENIN INHIBITORS

861

INVOLVING IGG3, IGG4, IGA, OR IGY

862

INVOLVING IGE OR IGD

863

INVOLVING IGM

864

. (1 indent ) Monoclonal

865

.. (2 indent ) Human

866

INVOLVING IMMUNOGLOBULIN OR ANTIBODY FRAGMENT, (E.G., F(AB)'2, FAB', FAB, FV, FC, HEAVY CHAIN, LIGHT CHAIN, ETC.)

867

INVOLVING IMMUNOGLOBULIN OR ANTIBODY PRODUCED VIA RECOMBINANT DNA TECHNOLOGY

868

INVOLVING AUTOIMMUNITY, ALLERGY, IMMEDIATE HYPERSENSITIVITY, DELAYED HYPERSENSITIVITY, IMMUNOSUPPRESSION, OR IMMUNOTOLERANCE

	FOREIGN ART COLLECTIONS

FOR000

CLASS-RELATED FOREIGN DOCUMENTS

   Note: Some content linked to on this page may require a plug-in for Adobe Acrobat Reader.

This file produced by USPTO - SIRA - Office of Patent Automation - ReferenceTools Project. Questions or comments relating to this file should be directed to Patent Automation Feedback.